Xenon Pharmaceuticals Statistics
NASDAQ: XENEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
35.44-0.97 (-2.66%)
Market open · Delayed 15 min · as of Oct 8, 12:43 PM ET
Xenon Pharmaceuticals by the numbers
Xenon Pharmaceuticals has a market capitalization of $3.43 billion based on 96.84M shares outstanding. With trailing EPS of $-4.74, Xenon Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.2% below its 50-day average and 33.1% below its 200-day average.
Average daily trading volume is 1.43M shares, or about $50.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XENE valuation vs. peer median
| Metric | XENE | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.43B | $3.51B | -2% |
| Avg. volume | 1.43M | 2.10M | -32% |
Peer median across 8 companies: LEGN, TNGX, VKTX, OGN, IDYA, PBLS, TLX, ACAD.
Valuation
- Market cap
- $3.43B
- Price / sales (latest FY)
- 457.60
- EPS (TTM)
- $-4.74
- Shares outstanding
- 96.84M
Price and trading
- Previous close
- 36.41
- Open
- 36.19
- Day range
- 35.06 – 36.41
- 52-week range
- 35.06 – 72.66
- 52-week change
- -7.02%
- Beta
- —
- Volume
- 938.73K
- Average volume
- 1.43M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 3.43B
- Forward Pe
- -7.52
- Eps
- -4.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 72.66
- Week52 Low
- 35.06
- Avg Volume
- 1.43M
- Shares Outstanding
- 96.84M
- Ma50
- 54.72
- Ma200
- 53.00
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -51.22%
- Pct From52w Low
- 1.08%